Tripathi, D <br/><br/>
Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.  [electronic resource] 

 -  Gut  Sep 2006 
 - 1290-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0017-5749 
<br/><br/><label>Standard No.: </label>10.1136/gut.2005.077453  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Double-Blind Method<br/>Endothelin A Receptor Antagonists<br/>Endothelin B Receptor Antagonists<br/>Endothelin-1--blood<br/>Female<br/>Hemodynamics--drug effects<br/>Humans<br/>Hypertension, Portal--drug therapy<br/>Liver Circulation--drug effects<br/>Liver Cirrhosis--physiopathology<br/>Male<br/>Middle Aged<br/>Oligopeptides--adverse effects<br/>Peptides, Cyclic--adverse effects<br/>Piperidines--adverse effects<br/>Pulmonary Circulation--drug effects